Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
102260.KS Stock Summary
In the News
102260.KS Financial details
Company Rating
Strong Buy
Market Cap
222.92B
Income
36.9B
Revenue
1118B
Book val./share
8132.41
Cash/share
3061.73
Dividend
200
Dividend %
4.55%
Employees
559
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
4.32
Forward P/E
-
PEG
-2.1
P/S
0.19
P/B
0.53
P/C
1.57
P/FCF
5.45
Quick Ratio
-
Current Ratio
1.32
Debt / Equity
0.46
LT Debt / Equity
-
-
-
EPS (TTM)
757.47
EPS next Y
-
EPS next Q
-
EPS this Y
-27.94%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.88%
Revenue last 5Y
5.64%
Revenue Q/Q
3.95%
EPS Q/Q
-83.03%
-
-
-
-
SMA20
2.64%
SMA50
9.08%
SMA100
14.62%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
13%
ROC
0.11%
Gross Margin
14%
Oper. Margin
6%
Profit Margin
4%
Payout
-
Shs Outstand
48.67M
Shs Float
27.38M
-
-
-
-
Target Price
-
52W Range
4075.0-5770.0
52W High
-16.46%
52W Low
+18.28%
RSI
57
Rel Volume
15.82
Avg Volume
78.52K
Volume
1.24M
Perf Week
6.64%
Perf Month
2.77%
Perf Quarter
15.59%
Perf Half Y
11.83%
-
-
-
-
Beta
0.79
-
-
Volatility
195.74%, 143.54%
Prev Close
-4.55%
Price
4820
Change
-6.77%
102260.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 19.3K | 20.09K | 19.18K | 23.23K | 22.49K | |
Net income per share | 568.37 | 846.92 | 858.28 | 954.02 | 1.14K | |
Operating cash flow per share | 1.04K | 2.8K | -338 | 1.08K | 0 | |
Free cash flow per share | 505.31 | 2.33K | -738.31 | 375.5 | 0 | |
Cash per share | 2.68K | 2.79K | 1.62K | 1.72K | 0 | |
Book value per share | 6.4K | 6.3K | 7.18K | 7.67K | 7.91K | |
Tangible book value per share | 8.67K | 8.93K | 8.72K | 9.22K | 19.6K | |
Share holders equity per share | 6.4K | 6.3K | 7.18K | 7.67K | 7.91K | |
Interest debt per share | 5.79K | 4.23K | 3.37K | 3.33K | 0 | |
Market cap | 229.79B | 217.1B | 231.52B | 224.83B | 222.61B | |
Enterprise value | 397.32B | 321.82B | 328.98B | 303.7B | 222.61B | |
P/E ratio | 9.18 | 5.84 | 5.59 | 4.8 | 3.94 | |
Price to sales ratio | 0.27 | 0.25 | 0.25 | 0.2 | 0.2 | |
POCF ratio | 5.04 | 1.77 | -14.19 | 4.23 | 0 | |
PFCF ratio | 10.33 | 2.12 | -6.49 | 12.2 | 0 | |
P/B Ratio | 0.82 | 0.78 | 0.67 | 0.6 | 0.57 | |
PTB ratio | 0.82 | 0.78 | 0.67 | 0.6 | 0.57 | |
EV to sales | 0.47 | 0.36 | 0.36 | 0.27 | 0.2 | |
Enterprise value over EBITDA | 4.9 | 3.5 | 3.84 | 3.49 | 2.75 | |
EV to operating cash flow | 8.72 | 2.62 | -20.16 | 5.71 | 0 | |
EV to free cash flow | 17.86 | 3.14 | -9.23 | 16.48 | 0 | |
Earnings yield | 0.11 | 0.17 | 0.18 | 0.21 | 0.25 | |
Free cash flow yield | 0.1 | 0.47 | -0.15 | 0.08 | 0 | |
Debt to equity | 0.88 | 0.64 | 0.45 | 0.42 | 0 | |
Debt to assets | 0.29 | 0.22 | 0.19 | 0.18 | 0 | |
Net debt to EBITDA | 2.07 | 1.14 | 1.14 | 0.91 | 0 | |
Current ratio | 1.29 | 1.16 | 1.25 | 1.3 | 0 | |
Interest coverage | 6.51 | 7.21 | 8.45 | 10.29 | 0 | |
Income quality | 1.82 | 3.3 | -0.38 | 1.14 | 0 | |
Dividend Yield | 0.05 | 0.09 | 0.1 | 0.09 | 0 | |
Payout ratio | 0.5 | 0.5 | 0.57 | 0.41 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0 | |
Capex to operating cash flow | -0.51 | -0.17 | 1.18 | -0.65 | 0 | |
Capex to revenue | -0.03 | -0.02 | -0.02 | -0.03 | 0 | |
Capex to depreciation | -0.87 | -0.75 | -0.75 | -1.48 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.05K | 10.96K | 11.78K | 12.83K | 14.23K | |
ROIC | 0.07 | 0.1 | 0.07 | 0.09 | 0.16 | |
Return on tangible assets | 0.03 | 0.05 | 0.05 | 0.05 | 0.06 | |
Graham Net | -3.24K | -2.46K | -1.77K | -1.96K | 0 | |
Working capital | 87.87B | 47.36B | 77.87B | 106.02B | 0 | |
Tangible asset value | 381.87B | 392.13B | 421.24B | 452.82B | 973.75B | |
Net current asset value | -42.18B | -20.98B | 32.56B | 47.18B | 0 | |
Invested capital | 0.88 | 0.64 | 0.45 | 0.42 | 0 | |
Average receivables | 142.63B | 123.22B | 132.11B | 164.73B | 85.77B | |
Average payables | 79.65B | 77.74B | 83.85B | 103.4B | 59.05B | |
Average inventory | 115.95B | 127B | 140.73B | 180.75B | 100.75B | |
Days sales outstanding | 60.2 | 43.99 | 62.25 | 54.92 | 0 | |
Days payables outstanding | 39.77 | 40.11 | 41.04 | 43.34 | 0 | |
Days of inventory on hand | 68.93 | 61.67 | 74.03 | 73.95 | 0 | |
Receivables turnover | 6.06 | 8.3 | 5.86 | 6.65 | 0 | |
Payables turnover | 9.18 | 9.1 | 8.89 | 8.42 | 0 | |
Inventory turnover | 5.3 | 5.92 | 4.93 | 4.94 | 0 | |
ROE | 0.09 | 0.13 | 0.12 | 0.12 | 0.14 | |
Capex per share | -529.7 | -464.08 | -400.31 | -707.96 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.12K | 5.78K | 6.08K | 5.45K | 5.66K | |
Net income per share | 307.56 | 211.28 | 223.71 | 276.39 | 46.9 | |
Operating cash flow per share | 1.3K | -723.68 | 1.11K | 1.49K | 872.81 | |
Free cash flow per share | 983.59 | -820.46 | 888.53 | 1.25K | 353.6 | |
Cash per share | 1.74K | 1.39K | 2.18K | 3.56K | 3.06K | |
Book value per share | 7.73K | 7.73K | 7.96K | 8.23K | 8.13K | |
Tangible book value per share | 9.3K | 9.23K | 9.58K | 10.03K | 10.2K | |
Share holders equity per share | 7.73K | 7.73K | 7.96K | 8.23K | 8.13K | |
Interest debt per share | 3.29K | 4.02K | 4.36K | 4.5K | 3.79K | |
Market cap | 222.93B | 215.79B | 218.46B | 211.17B | 218.06B | |
Enterprise value | 301.8B | 343.08B | 334.13B | 270.13B | 289.56B | |
P/E ratio | 3.72 | 5.25 | 5.02 | 3.93 | 23.88 | |
Price to sales ratio | 0.75 | 0.77 | 0.74 | 0.8 | 0.79 | |
POCF ratio | 3.52 | -6.13 | 4.03 | 2.91 | 5.13 | |
PFCF ratio | 4.66 | -5.41 | 5.05 | 3.47 | 12.67 | |
P/B Ratio | 0.59 | 0.57 | 0.56 | 0.53 | 0.55 | |
PTB ratio | 0.59 | 0.57 | 0.56 | 0.53 | 0.55 | |
EV to sales | 1.01 | 1.22 | 1.13 | 1.02 | 1.05 | |
Enterprise value over EBITDA | 41.37 | 8.97 | 7.42 | 5.39 | 12.05 | |
EV to operating cash flow | 4.77 | -9.74 | 6.16 | 3.72 | 6.82 | |
EV to free cash flow | 6.3 | -8.59 | 7.73 | 4.43 | 16.82 | |
Earnings yield | 0.07 | 0.05 | 0.05 | 0.06 | 0.01 | |
Free cash flow yield | 0.21 | -0.18 | 0.2 | 0.29 | 0.08 | |
Debt to equity | 0.42 | 0.5 | 0.54 | 0.54 | 0.46 | |
Debt to assets | 0.18 | 0.2 | 0.22 | 0.22 | 0.19 | |
Net debt to EBITDA | 10.81 | 3.33 | 2.57 | 1.18 | 2.98 | |
Current ratio | 1.3 | 1.26 | 1.31 | 1.32 | 1.25 | |
Interest coverage | 1.07 | 2.46 | 8.75 | 10.26 | 6.05 | |
Income quality | 3.54 | -3.43 | 3.06 | 3.28 | 18.61 | |
Dividend Yield | 0 | 0 | 0.04 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.89 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.08 | 0.08 | 0.09 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | |
Capex to operating cash flow | -0.24 | 0.13 | -0.2 | -0.16 | -0.59 | |
Capex to revenue | -0.05 | -0.02 | -0.04 | -0.04 | -0.09 | |
Capex to depreciation | -2.91 | -0.83 | -1.5 | -1.8 | -3.67 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.31K | 6.06K | 6.33K | 7.15K | 2.93K | |
ROIC | 0.01 | 0.02 | 0.03 | 0.03 | 0.04 | |
Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
Graham Net | -1.98K | -2.36K | -1.95K | -1.62K | -1.93K | |
Working capital | 106.02B | 100.53B | 112.37B | 130.08B | 101.82B | |
Tangible asset value | 452.82B | 449.1B | 466.35B | 488.08B | 496.7B | |
Net current asset value | 47.18B | 41.33B | 47.34B | 65.93B | 56.56B | |
Invested capital | 0.42 | 0.5 | 0.54 | 0.54 | 0.46 | |
Average receivables | 185.05B | 186.44B | 187.73B | 165.14B | 144.43B | |
Average payables | 109.2B | 113.03B | 96.05B | 90.93B | 91.24B | |
Average inventory | 204.54B | 207.04B | 205.14B | 204.26B | 208.72B | |
Days sales outstanding | 51.8 | 64.39 | 52.99 | 53 | 43.33 | |
Days payables outstanding | 39.45 | 39.96 | 30.2 | 40.9 | 33.16 | |
Days of inventory on hand | 67.32 | 78.67 | 70.97 | 88.22 | 80.85 | |
Receivables turnover | 1.74 | 1.4 | 1.7 | 1.7 | 2.08 | |
Payables turnover | 2.28 | 2.25 | 2.98 | 2.2 | 2.71 | |
Inventory turnover | 1.34 | 1.14 | 1.27 | 1.02 | 1.11 | |
ROE | 0.04 | 0.03 | 0.03 | 0.03 | 0.01 | |
Capex per share | -317 | -96.78 | -226.44 | -242.05 | -519.21 |
102260.KS Frequently Asked Questions
What is Dongsung Chemical Co., Ltd. stock symbol ?
Dongsung Chemical Co., Ltd. is a KR stock and trading under the symbol 102260.KS
What is Dongsung Chemical Co., Ltd. stock quote today ?
Dongsung Chemical Co., Ltd. stock price is $4820 today.
Is Dongsung Chemical Co., Ltd. stock public?
Yes, Dongsung Chemical Co., Ltd. is a publicly traded company.